gr 144053 has been researched along with aurintricarboxylic acid in 2 studies
| Studies (gr 144053) | Trials (gr 144053) | Recent Studies (post-2010) (gr 144053) | Studies (aurintricarboxylic acid) | Trials (aurintricarboxylic acid) | Recent Studies (post-2010) (aurintricarboxylic acid) |
|---|---|---|---|---|---|
| 21 | 1 | 2 | 558 | 0 | 84 |
| Protein | Taxonomy | gr 144053 (IC50) | aurintricarboxylic acid (IC50) |
|---|---|---|---|
| Inhibitor of nuclear factor kappa-B kinase subunit beta | Homo sapiens (human) | 5.4 | |
| Complement component C9 | Homo sapiens (human) | 0.5 | |
| 60 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 3.2 | |
| DNA-(apurinic or apyrimidinic site) endonuclease | Homo sapiens (human) | 3.37 | |
| DNA-3-methyladenine glycosylase | Homo sapiens (human) | 0.2 | |
| Cystathionine gamma-lyase | Homo sapiens (human) | 1.9667 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 1.8 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 3.3 | |
| Cystathionine beta-synthase | Homo sapiens (human) | 3 | |
| DNA repair protein RAD52 homolog | Homo sapiens (human) | 5 | |
| 10 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 3.2 | |
| 60 kDa chaperonin | Escherichia coli | 0.735 | |
| 10 kDa chaperonin | Escherichia coli | 0.735 | |
| Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens (human) | 0.017 | |
| DNA polymerase iota | Homo sapiens (human) | 0.075 | |
| DNA polymerase eta | Homo sapiens (human) | 0.075 | |
| Cysteine protease ATG4B | Homo sapiens (human) | 1.3 | |
| large T antigen | Betapolyomavirus macacae | 1.93 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, T; Kozawa, O; Matsuno, H; Niwa, M; Sakai, N; Uematsu, T | 1 |
| Boncler, M; Golanski, J; Rozalski, M; Watala, C | 1 |
2 other study(ies) available for gr 144053 and aurintricarboxylic acid
| Article | Year |
|---|---|
Comparison of the antithrombotic effects and bleeding risk of fractionated aurin tricarboxylic acid and the GPIIb/IIIa antagonist GR144053 in a hamster model of stenosis.
Topics: Animals; Aurintricarboxylic Acid; Carotid Stenosis; Catheterization; Cricetinae; Endothelium, Vascular; Hemorrhage; Infusions, Intravenous; Male; Mesocricetus; Piperazines; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex | 1999 |
Effects of fibrinogen receptor antagonist GR144053F and aurintricarboxylic acid on platelet activation and degranulation.
Topics: Adenosine Diphosphate; Adult; Aurintricarboxylic Acid; Cell Degranulation; Collagen Type I; Female; Flow Cytometry; Hemostasis; Humans; Male; Middle Aged; Piperazines; Piperidines; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex | 2001 |